Showing 1 - 1 results of 1 for search 'on Behalf of the K-877 Study Group', query time: 0.02s
Refine Results
-
1
Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment by Koutaro Yokote, Shizuya Yamashita, Hidenori Arai, Eiichi Araki, Hideki Suganami, Shun Ishibashi, on Behalf of the K-877 Study Group
Published 2019-02-01
Article